TIDES 2026—Hybridization LC-MS/MS: A Selective Solution for PMO and PPMO Bioanalysis

Recording by Mingluan Chen, PhD, Principal Research Scientist (MD). Presented by Kevork Mekhssian, Senior Scientific Director, Mass Spectrometry, at the TIDES 2026 in Boston, MA. 📧 Contact us: https://www.altasciences.com/contact-us#inquiry About Altasciences: For over 30 years, Altasciences has been reimagining drug development for biopharmaceutical companies in support of quick and informed decision-making to help bring better drugs to the people who need them, faster. From lead candidate selection to proof of concept, we offer an acceleration platform, intentionally designed with flexibility and integration, so that programs reach milestones sooner, without compromising scientific excellence or quality. Our full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… Drug Development, Reimagined.